JP2006008676A5 - - Google Patents

Download PDF

Info

Publication number
JP2006008676A5
JP2006008676A5 JP2005154761A JP2005154761A JP2006008676A5 JP 2006008676 A5 JP2006008676 A5 JP 2006008676A5 JP 2005154761 A JP2005154761 A JP 2005154761A JP 2005154761 A JP2005154761 A JP 2005154761A JP 2006008676 A5 JP2006008676 A5 JP 2006008676A5
Authority
JP
Japan
Prior art keywords
weight
tablet
pranlukast hydrate
parts
tablet according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005154761A
Other languages
English (en)
Japanese (ja)
Other versions
JP4742679B2 (ja
JP2006008676A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005154761A priority Critical patent/JP4742679B2/ja
Priority claimed from JP2005154761A external-priority patent/JP4742679B2/ja
Publication of JP2006008676A publication Critical patent/JP2006008676A/ja
Publication of JP2006008676A5 publication Critical patent/JP2006008676A5/ja
Application granted granted Critical
Publication of JP4742679B2 publication Critical patent/JP4742679B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2005154761A 2004-05-27 2005-05-27 固形製剤用組成物 Expired - Lifetime JP4742679B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005154761A JP4742679B2 (ja) 2004-05-27 2005-05-27 固形製剤用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004158371 2004-05-27
JP2004158371 2004-05-27
JP2005154761A JP4742679B2 (ja) 2004-05-27 2005-05-27 固形製剤用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006128983A Division JP2006206612A (ja) 2004-05-27 2006-05-08 固形製剤用組成物

Publications (3)

Publication Number Publication Date
JP2006008676A JP2006008676A (ja) 2006-01-12
JP2006008676A5 true JP2006008676A5 (https=) 2006-04-20
JP4742679B2 JP4742679B2 (ja) 2011-08-10

Family

ID=35776304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005154761A Expired - Lifetime JP4742679B2 (ja) 2004-05-27 2005-05-27 固形製剤用組成物

Country Status (1)

Country Link
JP (1) JP4742679B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596610A (en) 2009-05-27 2014-04-30 Samyang Biopharmaceuticals A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same
WO2022003980A1 (ja) * 2020-07-03 2022-01-06 富士製薬工業株式会社 固形製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2958863B2 (ja) * 1995-06-12 1999-10-06 小野薬品工業株式会社 プランルカストを含有する造粒物、その製造方法およびプランルカストの付着凝集性改善方法
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법

Similar Documents

Publication Publication Date Title
RU2010101797A (ru) Фармацевтический твердый препарат, содержащий бензазепины и способ его получения
JPS58403B2 (ja) L− アスコルビンサンセイザイノ セイゾウホウ
KR20110116006A (ko) 제어 방출형 약학적 제제 또는 식품 제제 및 이의 제조 방법
CN101658505A (zh) 非布索坦的缓释制剂及其制备方法
JP2014024874A5 (https=)
CN110420192B (zh) 一种单硝酸异山梨酯缓释片及制备方法
JP2022051776A (ja) 賦形剤及び錠剤
CA2648667A1 (en) Sustained-release tablet production process
CN102309462B (zh) 一种阿托伐他汀钙片剂
JP2006008676A5 (https=)
JPWO2008059652A1 (ja) 崩壊剤、並びにそれが含まれた錠剤及び顆粒
TW202014204A (zh) 含有崩解劑成分及微小纖維狀纖維素之崩解性固形物
JP4774739B2 (ja) 漢方エキス含有錠剤組成物およびその製造方法
JP5286662B2 (ja) 安中散含有錠剤
CN102349876A (zh) 一种治疗胃溃疡和十二指肠溃疡的药物及其配制方法
WO2008081774A1 (ja) リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
CN104382873B (zh) 一种吗替麦考酚酯分散片
CN111214451A (zh) 一种盐酸丁螺环酮胃漂浮缓释片的制备方法
CN103690503B (zh) 一种双层片的制备方法
TW200732000A (en) Orally disintegrating table comprising fat-soluble drug
CN101461815B (zh) 三氟柳药物组合物及其制备方法
CN103655504B (zh) 右旋酮洛芬氨丁三醇速释缓释双层片及其制备工艺
JP4934314B2 (ja) 安定な塩酸サルポグレラート含有錠剤の製造法
CN107744509B (zh) 枸橼酸莫沙必利片剂及其制备方法
WO2007026261A3 (en) Formulations containing losartan and/or its salts